Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 0.125MG MIRAPEX PHARMACIA AND UPJOHN | 020667 PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 0.25MG MIRAPEX PHARMACIA AND UPJOHN | 020667 PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 0.5MG MIRAPEX PHARMACIA AND UPJOHN | 020667 PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 1.5MG MIRAPEX PHARMACIA AND UPJOHN | 020667 PRAMIPEXOLE DIHYDROCHLORIDE Tablet; 1MG MIRAPEX PHARMACIA AND UPJOHN | MIRAPEX (pramipexole dihydrochloride) Tablets, Boehringer Ingelheim, New or Modified Indication | Pramipexole Dihydrochloride Tablets, Barr Labs, Tentative Approval | Pramipexole Dihydrochloride Tablets, Barr Labs, Approval | Mirapex (pramipexole dihydrochloride) Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Labeling Revision | Pramipexole Dihydrochloride Tablets, Alembic, Ltd., Tentative Approval | Pramipexole Dihydrochloride Tablets, Glenmark Generics Limited, Tentative Approval | Mirapex ER (pramipexole dihydrochloride) Extended-Release Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Approval | Mirapex ER (pramipexole dihydrochloride) Extended-Release Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Approval | Pramipexole Dihydrochloride Tablets, Sandoz, Inc., Tentative Approval | Pramipexole Dihydrochloride Tablets, Mylan Pharmaceuticals, Inc., Approval | Pramipexole Dihydrochloride Tablets, Torrent Pharmaceuticals, Tentative Approval | Pramipexole Dihydrochloride Tablets, Zydus Pharmaceuticals, Tentative Approval | Mirapex ER (pramipexole dihydrochloride) Extended-Release Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Labeling Revision | Pramipexole Dihydrochloride Tablets, Zydus Pharmaceuticals, Approval | Pramipexole Dihydrochloride Tablets, Sandoz Inc., Approval | Pramipexole Dihydrochloride Tablets, Sandoz, Inc., Approval | Pramipexole Dihydrochloride Tablets, Actavis Pharma Manufacturing, Approval | Mirapex (pramipexole dihydrochloride) Tablets, Boehringer Ingelheim Pharmaceuticals, Inc., Efficacy Supplement ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com